Safety and Efficacy of Sufentanil NanoTab for Management of Acute Pain Following Bunionectomy

• Status: Completed
• Trial end date: 2013-02-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a dose-finding study to determine if the sublingual administration of the Sufentanil NanoTab is safe and effective in the treatment of post-operative pain.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AcelRx Pharmaceuticals, Inc.
• Treatments: Dsuvia; Sufentanil

Criteria

Inclusion Criteria:

• patients scheduled for bunion surgery

Exclusion Criteria:

• daily opioid use

• drug or alcohol abuse

• pregnant or breastfeeding women